ReviewCancer science2020

FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development.

Hitoshi Kiyoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.